Pres. Biden's administration on Thursday unveiled a new framework allowing authorities the right to seize certain drug patents and license them to other manufacturers in order to lower drug prices.

Coherus BioSciences will launch Yusimry – used to treat rheumatoid arthritis and psoriasis – which Cuban's Cost Plus Drugs will be offering starting in July.

The Biden administration had promised to give states 60 days notice before ending the public health emergency to allow sufficient time to prepare for changes to programs and regulatory authorities.

Over the next decade, J&J will bet big on gene therapies.

Johnson & Johnson is following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.

For drugmakers, the pandemic has squeezed demand for everything from childhood vaccines to smoking-cessation drugs.

The order comes after an earlier attempt to force pharmaceutical companies to make reductions didn't yield results.

New policies announced Friday aimed at lowering drug prices under Medicare would link prices to rates paid in other countries.